Diabetes visits in paediatric versus adult clinics for young adults (YA) with T1D: Pre-pandemic and pandemic care
- PMID: 39826105
- PMCID: PMC12005977
- DOI: 10.1111/dme.15509
Diabetes visits in paediatric versus adult clinics for young adults (YA) with T1D: Pre-pandemic and pandemic care
Abstract
Background: Young adults (YA) with type 1 diabetes mellitus (T1D) are at high risk of worsening glycated haemoglobin (HbA1c) with fewer follow-up visits. We examined the association of demographic and diabetes characteristics with care utilization, including in-person and telehealth visits, pre- (1 April 2019 to 15 March 2020) and during the COVID-19 pandemic (30 March 2020 to 15 March 2021) for YA (ages: 18-30) with T1D, comparing those seen in paediatric versus adult diabetes clinics at a single diabetes centre.
Methods: Data were obtained from the electronic health record for YA with a pre-pandemic HbA1c. We performed descriptive statistics to describe the sample and paired t-tests to compare visits before and during the pandemic.
Results: Data from 1762 YA (54% male; age 24.0 ± 3.6 (M ± SD) years; HbA1c 66 ± 18 mmol/mol (8.2 ± 1.6%) revealed that in the full sample, mean pre-pandemic visit frequency was 3.5 ± 3.4 and mean pandemic visit frequency was 3.1 ± 4.1 (p < 0.0001). Furthermore, the pandemic visit frequency declined in the adult clinic regardless of sex, pump therapy, CGM use, and pre-pandemic HbA1c, whereas in the paediatric clinic, visit frequency was only reduced for those with HbA1c <53 mmol/mol (<7%) but was otherwise maintained.
Conclusions: In this diabetes centre, the paediatric clinic maintained diabetes care delivery during the pandemic (30 March 2020 to 15 March 2021) to YA with glycaemic control above target, suggesting that preservation of remote care delivery should be considered in this high-risk group.
Keywords: Diabetes Care Delivery; Telehealth; Type 1 Diabetes; Young Adults.
© 2025 Diabetes UK.
Conflict of interest statement
Similar articles
-
Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4197-e4202. doi: 10.1210/clinem/dgac476. J Clin Endocrinol Metab. 2022. PMID: 35948357 Free PMC article.
-
Overcoming Barriers to Diabetes Management in Young Adults with Type 1 Diabetes by Leveraging Telehealth: A Pilot Study.Endocr Pract. 2024 Feb;30(2):135-140. doi: 10.1016/j.eprac.2023.11.005. Epub 2023 Nov 24. Endocr Pract. 2024. PMID: 38008258
-
Rapid Adoption of Telemedicine Along with Emergent Use of Continuous Glucose Monitors in the Ambulatory Care of Young Persons with New-Onset Type 1 Diabetes in the Time of COVID-19: A Case Series.Telemed J E Health. 2022 Jan;28(1):107-114. doi: 10.1089/tmj.2020.0554. Epub 2021 Apr 15. Telemed J E Health. 2022. PMID: 33857385 Free PMC article.
-
Diabetes technology and treatments in the paediatric age group.Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Int J Clin Pract Suppl. 2011. PMID: 21323816 Review.
-
The impact of telemedicine on pediatric type 1 diabetes management: benefits, challenges, and future directions.Front Endocrinol (Lausanne). 2024 Dec 20;15:1513166. doi: 10.3389/fendo.2024.1513166. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39758346 Free PMC article. Review.
References
-
- Arnett J, Kloep M, Hendry L, Tanner J. Debating Emerging Adulthood. Stage or Process? : Oxford University Press; 2011.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous